当前位置: 首页 > 期刊 > 《中国现代医生》 > 2022年第12期
编号:668425
PET/CT在不可手术的早期肺癌立体定向放疗中的应用
http://www.100md.com 2022年6月22日 中国现代医生 2022年第12期
     陈奎妃 陈梦 侯利桥 孟胤男 王微 周苏娜 杨海华

    [摘要] 肺癌是世界范围内最常见的癌症之一,也是目前癌症死亡的主要原因。近年来随着低剂量CT筛查的普及,早期肺癌的发现率逐步提高。随着放疗设备及技术的不断发展,特别是体部立体定向放射治疗(SBRT)在早期不能手术的肺癌患者治疗中的地位愈加重要,已成为不可手术的早期肺癌的标准治疗方式。正电子发射计算机断层显像(PET/CT)通过对肿瘤病灶进行定性和定量分析,可以明确肺癌诊断分期,指导放射治疗中的靶区勾画,同时也提供更丰富的后期生物学评估的方法。该文就PET/CT在不可手术的早期肺癌SBRT前、中、后的应用进行概述。

    [关键词] 肺癌;SBRT;PET/CT;直线加速器

    [中图分类号] R734.2? ? ? ? ? [文献标识码] A? ? ? ? ? [文章编号] 1673-9701(2022)12-0192-05

    [Abstract] Lung cancer is one of the most common cancers in the world and the leading cause of cancer death. In recent years, with the popularization of low-dose CT screening, the detection rate of early-staged LC has gradually increased. With the continuous development of radiotherapy equipment and technology, especially stereotactic body radiation therapy (SBRT) has been increasingly important in the treatment of patients with medically inoperable LC at early stage, and has become the standard treatment for medically inoperable LC at early stage. Positron emission tomography/computed tomography (PET/CT) can clarify the diagnosis and staging of LC through qualitative and quantitative analysis of tumor lesions ......

您现在查看是摘要页,全文长 16364 字符